Hiroaki Shiina

6.6k total citations
198 papers, 4.6k citations indexed

About

Hiroaki Shiina is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Hiroaki Shiina has authored 198 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Molecular Biology, 73 papers in Pulmonary and Respiratory Medicine and 68 papers in Surgery. Recurrent topics in Hiroaki Shiina's work include Bladder and Urothelial Cancer Treatments (40 papers), Prostate Cancer Treatment and Research (39 papers) and Epigenetics and DNA Methylation (29 papers). Hiroaki Shiina is often cited by papers focused on Bladder and Urothelial Cancer Treatments (40 papers), Prostate Cancer Treatment and Research (39 papers) and Epigenetics and DNA Methylation (29 papers). Hiroaki Shiina collaborates with scholars based in Japan, United States and South Korea. Hiroaki Shiina's co-authors include Mikio Igawa, Shinji Urakami, Rajvir Dahiya, Kazushi Shigeno, Hideki Enokida, Yuichiro Tanaka, Nobuyuki Kikuno, Tatsuaki Yoneda, Toshifumi Kawakami and Masaharu Terashima and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Hiroaki Shiina

187 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroaki Shiina Japan 42 2.5k 1.2k 1.1k 720 605 198 4.6k
Gaëlle Fromont France 35 1.7k 0.7× 2.0k 1.7× 1.1k 1.0× 825 1.1× 622 1.0× 163 4.8k
Hiroshi Kanetake Japan 34 2.0k 0.8× 1.1k 0.9× 959 0.9× 899 1.2× 796 1.3× 210 4.1k
Keiichi Ito Japan 34 1.3k 0.5× 943 0.8× 932 0.8× 572 0.8× 511 0.8× 349 4.3k
Haruhito Azuma Japan 41 1.8k 0.7× 993 0.8× 2.0k 1.8× 669 0.9× 601 1.0× 259 5.7k
Zhangqun Ye China 37 2.4k 1.0× 1.4k 1.2× 818 0.7× 531 0.7× 1.6k 2.6× 219 4.8k
Tetsuya Fujimura Japan 35 1.4k 0.6× 1.2k 1.1× 729 0.7× 686 1.0× 766 1.3× 205 3.8k
Adrie van Bokhoven United States 35 2.5k 1.0× 1.6k 1.4× 379 0.3× 992 1.4× 1.1k 1.7× 74 4.6k
Jeffrey R. Gingrich United States 26 1.5k 0.6× 1.1k 0.9× 419 0.4× 796 1.1× 502 0.8× 78 3.3k
Noboru Konishi Japan 45 3.0k 1.2× 1.2k 1.0× 883 0.8× 1.4k 2.0× 1.2k 1.9× 239 6.3k
Mark Garzotto United States 32 1.0k 0.4× 1.9k 1.6× 411 0.4× 790 1.1× 854 1.4× 118 3.8k

Countries citing papers authored by Hiroaki Shiina

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Shiina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Shiina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Shiina more than expected).

Fields of papers citing papers by Hiroaki Shiina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Shiina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Shiina. The network helps show where Hiroaki Shiina may publish in the future.

Co-authorship network of co-authors of Hiroaki Shiina

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Shiina. A scholar is included among the top collaborators of Hiroaki Shiina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Shiina. Hiroaki Shiina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishimoto, Koshiro, Kenichi Nakajima, Masafumi Oyama, et al.. (2022). Predictive factors for the effectiveness of novel androgen receptor axis‐targeted agents in patients with metastatic prostate cancer. International Journal of Urology. 29(12). 1477–1487. 2 indexed citations
2.
Mizokami, Atsushi, Koshiro Nishimoto, Hideyasu Matsuyama, et al.. (2022). Efficacy of New Therapies for Relapse After Docetaxel Treatment of Bone Metastatic Castration-resistant Prostate Cancer in Clinical Practice. Anticancer Research. 42(3). 1465–1475. 2 indexed citations
3.
Maruyama, Yuki, Takuya Sadahira, Yasuhiro Nishiyama, et al.. (2021). Efficacy of holmium laser enucleation in patients with a small (less than 30 mL) prostate volume. Investigative and Clinical Urology. 62(3). 298–298. 3 indexed citations
4.
Yoshida, Takashi, Takashi Kobayashi, Makito Miyake, et al.. (2020). Development and external validation of a preoperative nomogram for predicting pathological locally advanced disease of clinically localized upper urinary tract carcinoma. Cancer Medicine. 9(11). 3733–3741. 13 indexed citations
5.
Yoshizako, Takeshi, et al.. (2019). T1a renal cell carcinoma on unenhanced CT: analysis of detectability and imaging features. Acta Radiologica Open. 8(5). 2553961194–2553961194. 2 indexed citations
6.
Ishikawa, Noriyoshi, et al.. (2019). Xp11.2 translocation renal cell carcinoma with SFPQ/PSF-TFE3 fusion gene: A case report with unusual histopathologic findings. Pathology - Research and Practice. 215(9). 152479–152479. 2 indexed citations
7.
Ishikawa, Noriyoshi, et al.. (2016). A Case Report of Bilateral Sarcomatoid Carcinoma of Adrenal Glands With Adrenal Insufficiency. International Journal of Surgical Pathology. 24(8). 743–748. 8 indexed citations
8.
Mitsui, Yozo, Hiroaki Yasumoto, Naoko Arichi, et al.. (2011). Current chemotherapeutic strategies against bladder cancer. International Urology and Nephrology. 44(2). 431–441. 6 indexed citations
9.
Kawakami, Toshifumi, Shinji Urakami, Hiroshi Hirata, et al.. (2009). Superoxide dismutase analog (Tempol: 4-hydroxy-2, 2, 6, 6-tetramethylpiperidine 1-oxyl) treatment restores erectile function in diabetes-induced impotence. International Journal of Impotence Research. 21(6). 348–355. 15 indexed citations
10.
Tanaka, Yuichiro, Mohd Saif Zaman, Shahana Majid, et al.. (2009). Polymorphisms of MLH1 in benign prostatic hyperplasia and sporadic prostate cancer. Biochemical and Biophysical Research Communications. 383(4). 440–444. 11 indexed citations
11.
Shiina, Hiroaki, Mayumi Mizutani, & Tomoyuki Ishibe. (2009). Estramustine binding protein in human benign prostatic hypertrophy. Andrologia. 22(4). 309–312. 1 indexed citations
12.
Urakami, Shinji, Hiroaki Shiina, Hideki Enokida, et al.. (2006). 606: Wnt Inhibitory Factor-1 Plays an Important Role in Pathogenesis of Bladder Cancer Through the Epigenetic Inactivation. The Journal of Urology. 175(4S). 196–196. 1 indexed citations
13.
Youssif, Mohamed, Hiroaki Shiina, Shinji Urakami, et al.. (2005). Effect of vascular endothelial growth factor on regeneration of bladder acellular matrix graft: Histologic and functional evaluation. Urology. 66(1). 201–207. 40 indexed citations
14.
Yamanaka, Masaki, Masato Shirai, Hiroaki Shiina, et al.. (2003). Diabetes Induced Erectile Dysfunction and Apoptosis in Penile Crura are Recovered by Insulin Treatment in Rats. The Journal of Urology. 170(1). 291–297. 48 indexed citations
15.
Ribeiro‐Filho, Leopoldo Alves, Masahiro Sasaki, Hiroaki Shiina, et al.. (2002). CpG hypermethylation of promoter region and inactivation of E‐cadherin gene in human bladder cancer. Molecular Carcinogenesis. 34(4). 187–198. 71 indexed citations
16.
Igawa, Mikio, et al.. (1999). Inverted Papilloma of the Urinary Bladder in a Girl. Urologia Internationalis. 63(4). 258–260. 7 indexed citations
17.
Jidoi, Joji, et al.. (1996). Genital Paget's Disease: Report of a Case Which Developed after Prostatic Carcinoma and was Followed by Hepatocellular Carcinoma.. The Nishinihon Journal of Dermatology. 58(4). 604–607.
18.
Shiina, Hiroaki, Shinji Urakami, Hiroki Shirakawa, et al.. (1996). Evaluation of the ArgyrophilicNucleolar Organizer Region,Nuclear DNA Content and MeanNuclear Area in Transitional CellCarcinoma of Bladder Using aQuantitative Image Analyzer. European Urology. 29(1). 99–105. 8 indexed citations
19.
Igawa, Mikio, et al.. (1995). Long‐term results with M‐VAC for advanced urothelial cancer: high relapse rate and low survival in patients with a complete response. British Journal of Urology. 76(3). 321–324. 19 indexed citations
20.
Shiina, Hiroaki, Tomoyuki Ishibe, & Toshio Usui. (1993). Interaction of testosterone-oestradiol binding globulin (TeBG) and albumin with human prostatic carcinoma in vitro.. PubMed. 25(6). 577–82. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gaëlle Fromont Breakdown of academic impact, for papers by Hiroshi Kanetake Breakdown of academic impact, for papers by Keiichi Ito Breakdown of academic impact, for papers by Haruhito Azuma Breakdown of academic impact, for papers by Zhangqun Ye Breakdown of academic impact, for papers by Tetsuya Fujimura Breakdown of academic impact, for papers by Adrie van Bokhoven Breakdown of academic impact, for papers by Jeffrey R. Gingrich Breakdown of academic impact, for papers by Noboru Konishi Breakdown of academic impact, for papers by Mark Garzotto
Rankless by CCL
2026